Skip to main content
. 2023 Feb 16;16(5):104676. doi: 10.1016/j.arabjc.2023.104676

Fig. 6.

Fig. 6

(A) Cell viability % toward HepG-2 cell line at concentrations 31.25–500 μg/mL for (CS), (CS) derivatives and its derivatives NPs. (B) Cell viability % toward MCF-7 cells line at concentrations 31.25–500 μg/mL for (CS), (CS) derivatives and its derivatives NPs.